A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

NCT03082053 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced or Metastatic Biliary Tract Cancer
Advanced or Metastatic Solid Tumors

Interventions

DRUG: varlitinib
DRUG: capecitabine

Sponsor

ASLAN Pharmaceuticals